A new cancer immunotherapy suffers a setback – Science Magazine
Science MagazineA new cancer immunotherapy suffers a setbackScience MagazineThe surprising failure last month of a large clinical trial of a promising cancer immunotherapy drug from the biotech company Incyte has quickly reverberated across the pharmac… Continue reading
